Global Mental Disorder Treatment Market Research Report 2023

Mental Disorder Treatment Market

A mental disorder is also called as mental illness or a psychiatric disorder. Mental disorders are generally defined according to how an individual behave, feels, perceives and thinks, and mental disorder occurs due to damage or problems associated with functions of brain. There are various types of mental disorders such as depression, bipolar disorder, schizophrenia and other psychoses, dementia, and developmental disorders including autism.

These disorders can be treated with the help of various medications such as anti-depressants, antianxiety drugs and can also be treated with self-help therapies such as psychotherapy, brain stimulation treatments, and others.

The global Mental Disorder Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Mental Disorder Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Mental Disorder Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Mental Disorder Treatment in Depression is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Mental Disorder Treatment include Allergan Plc, Eli Lilly and Company, VistaGen Therapeutics, Sanofi S.A, Novartis International AG, Mylan N.V, Amneal Pharmaceuticals LLC, Cipla Ltd and Sun Pharmaceutical Industries Ltd, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mental Disorder Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mental Disorder Treatment.

The Mental Disorder Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Mental Disorder Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Mental Disorder Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Scope of Mental Disorder Treatment Market Report

Core Chapters

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Mental Disorder Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Medications

1.2.3 Self-help Therapies

1.3 Market by Application

1.3.1 Global Mental Disorder Treatment Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Depression

1.3.3 Bipolar Disorder

1.3.4 Schizophrenia

1.3.5 Dementia

1.3.6 Post-traumatic Stress Disorder

1.3.7 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Mental Disorder Treatment Market Perspective (2018-2029)

2.2 Mental Disorder Treatment Growth Trends by Region

2.2.1 Global Mental Disorder Treatment Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Mental Disorder Treatment Historic Market Size by Region (2018-2023)

2.2.3 Mental Disorder Treatment Forecasted Market Size by Region (2024-2029)

2.3 Mental Disorder Treatment Market Dynamics

2.3.1 Mental Disorder Treatment Industry Trends

2.3.2 Mental Disorder Treatment Market Drivers

2.3.3 Mental Disorder Treatment Market Challenges

2.3.4 Mental Disorder Treatment Market Restraints

3.1 Global Top Mental Disorder Treatment Players by Revenue

3.1.1 Global Top Mental Disorder Treatment Players by Revenue (2018-2023)

3.1.2 Global Mental Disorder Treatment Revenue Market Share by Players (2018-2023)

3.2 Global Mental Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Mental Disorder Treatment Revenue

3.4 Global Mental Disorder Treatment Market Concentration Ratio

3.4.1 Global Mental Disorder Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Mental Disorder Treatment Revenue in 2022

3.5 Mental Disorder Treatment Key Players Head office and Area Served

3.6 Key Players Mental Disorder Treatment Product Solution and Service

3.7 Date of Enter into Mental Disorder Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Mental Disorder Treatment Historic Market Size by Type (2018-2023)

4.2 Global Mental Disorder Treatment Forecasted Market Size by Type (2024-2029)

5.1 Global Mental Disorder Treatment Historic Market Size by Application (2018-2023)

5.2 Global Mental Disorder Treatment Forecasted Market Size by Application (2024-2029)

6.1 North America Mental Disorder Treatment Market Size (2018-2029)

6.2 North America Mental Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Mental Disorder Treatment Market Size by Country (2018-2023)

6.4 North America Mental Disorder Treatment Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Mental Disorder Treatment Market Size (2018-2029)

7.2 Europe Mental Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Mental Disorder Treatment Market Size by Country (2018-2023)

7.4 Europe Mental Disorder Treatment Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Mental Disorder Treatment Market Size (2018-2029)

8.2 Asia-Pacific Mental Disorder Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Mental Disorder Treatment Market Size by Region (2018-2023)

8.4 Asia-Pacific Mental Disorder Treatment Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Mental Disorder Treatment Market Size (2018-2029)

9.2 Latin America Mental Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Mental Disorder Treatment Market Size by Country (2018-2023)

9.4 Latin America Mental Disorder Treatment Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Mental Disorder Treatment Market Size (2018-2029)

10.2 Middle East & Africa Mental Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Mental Disorder Treatment Market Size by Country (2018-2023)

10.4 Middle East & Africa Mental Disorder Treatment Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Allergan Plc

11.1.1 Allergan Plc Company Detail

11.1.2 Allergan Plc Business Overview

11.1.3 Allergan Plc Mental Disorder Treatment Introduction

11.1.4 Allergan Plc Revenue in Mental Disorder Treatment Business (2018-2023)

11.1.5 Allergan Plc Recent Development

11.2 Eli Lilly and Company

11.2.1 Eli Lilly and Company Company Detail

11.2.2 Eli Lilly and Company Business Overview

11.2.3 Eli Lilly and Company Mental Disorder Treatment Introduction

11.2.4 Eli Lilly and Company Revenue in Mental Disorder Treatment Business (2018-2023)

11.2.5 Eli Lilly and Company Recent Development

11.3 VistaGen Therapeutics

11.3.1 VistaGen Therapeutics Company Detail

11.3.2 VistaGen Therapeutics Business Overview

11.3.3 VistaGen Therapeutics Mental Disorder Treatment Introduction

11.3.4 VistaGen Therapeutics Revenue in Mental Disorder Treatment Business (2018-2023)

11.3.5 VistaGen Therapeutics Recent Development

11.4 Sanofi S.A

11.4.1 Sanofi S.A Company Detail

11.4.2 Sanofi S.A Business Overview

11.4.3 Sanofi S.A Mental Disorder Treatment Introduction

11.4.4 Sanofi S.A Revenue in Mental Disorder Treatment Business (2018-2023)

11.4.5 Sanofi S.A Recent Development

11.5 Novartis International AG

11.5.1 Novartis International AG Company Detail

11.5.2 Novartis International AG Business Overview

11.5.3 Novartis International AG Mental Disorder Treatment Introduction

11.5.4 Novartis International AG Revenue in Mental Disorder Treatment Business (2018-2023)

11.5.5 Novartis International AG Recent Development

11.6 Mylan N.V

11.6.1 Mylan N.V Company Detail

11.6.2 Mylan N.V Business Overview

11.6.3 Mylan N.V Mental Disorder Treatment Introduction

11.6.4 Mylan N.V Revenue in Mental Disorder Treatment Business (2018-2023)

11.6.5 Mylan N.V Recent Development

11.7 Amneal Pharmaceuticals LLC

11.7.1 Amneal Pharmaceuticals LLC Company Detail

11.7.2 Amneal Pharmaceuticals LLC Business Overview

11.7.3 Amneal Pharmaceuticals LLC Mental Disorder Treatment Introduction

11.7.4 Amneal Pharmaceuticals LLC Revenue in Mental Disorder Treatment Business (2018-2023)

11.7.5 Amneal Pharmaceuticals LLC Recent Development

11.8 Cipla Ltd

11.8.1 Cipla Ltd Company Detail

11.8.2 Cipla Ltd Business Overview

11.8.3 Cipla Ltd Mental Disorder Treatment Introduction

11.8.4 Cipla Ltd Revenue in Mental Disorder Treatment Business (2018-2023)

11.8.5 Cipla Ltd Recent Development

11.9 Sun Pharmaceutical Industries Ltd

11.9.1 Sun Pharmaceutical Industries Ltd Company Detail

11.9.2 Sun Pharmaceutical Industries Ltd Business Overview

11.9.3 Sun Pharmaceutical Industries Ltd Mental Disorder Treatment Introduction

11.9.4 Sun Pharmaceutical Industries Ltd Revenue in Mental Disorder Treatment Business (2018-2023)

11.9.5 Sun Pharmaceutical Industries Ltd Recent Development

11.10 Glenmark Pharmaceuticals Limited

11.10.1 Glenmark Pharmaceuticals Limited Company Detail

11.10.2 Glenmark Pharmaceuticals Limited Business Overview

11.10.3 Glenmark Pharmaceuticals Limited Mental Disorder Treatment Introduction

11.10.4 Glenmark Pharmaceuticals Limited Revenue in Mental Disorder Treatment Business (2018-2023)

11.10.5 Glenmark Pharmaceuticals Limited Recent Development

11.11 Lupin Limited

11.11.1 Lupin Limited Company Detail

11.11.2 Lupin Limited Business Overview

11.11.3 Lupin Limited Mental Disorder Treatment Introduction

11.11.4 Lupin Limited Revenue in Mental Disorder Treatment Business (2018-2023)

11.11.5 Lupin Limited Recent Development

11.12 Janssen Pharmaceutica

11.12.1 Janssen Pharmaceutica Company Detail

11.12.2 Janssen Pharmaceutica Business Overview

11.12.3 Janssen Pharmaceutica Mental Disorder Treatment Introduction

11.12.4 Janssen Pharmaceutica Revenue in Mental Disorder Treatment Business (2018-2023)

11.12.5 Janssen Pharmaceutica Recent Development

11.13 Bristol Myers Squibb

11.13.1 Bristol Myers Squibb Company Detail

11.13.2 Bristol Myers Squibb Business Overview

11.13.3 Bristol Myers Squibb Mental Disorder Treatment Introduction

11.13.4 Bristol Myers Squibb Revenue in Mental Disorder Treatment Business (2018-2023)

11.13.5 Bristol Myers Squibb Recent Development

11.14 Sumitomo Dainippon Pharma Co., Ltd

11.14.1 Sumitomo Dainippon Pharma Co., Ltd Company Detail

11.14.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview

11.14.3 Sumitomo Dainippon Pharma Co., Ltd Mental Disorder Treatment Introduction

11.14.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Mental Disorder Treatment Business (2018-2023)

11.14.5 Sumitomo Dainippon Pharma Co., Ltd Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Mental Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Medications

    Table 3. Key Players of Self-help Therapies

    Table 4. Global Mental Disorder Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Mental Disorder Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Mental Disorder Treatment Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Mental Disorder Treatment Market Share by Region (2018-2023)

    Table 8. Global Mental Disorder Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Mental Disorder Treatment Market Share by Region (2024-2029)

    Table 10. Mental Disorder Treatment Market Trends

    Table 11. Mental Disorder Treatment Market Drivers

    Table 12. Mental Disorder Treatment Market Challenges

    Table 13. Mental Disorder Treatment Market Restraints

    Table 14. Global Mental Disorder Treatment Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Mental Disorder Treatment Market Share by Players (2018-2023)

    Table 16. Global Top Mental Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mental Disorder Treatment as of 2022)

    Table 17. Ranking of Global Top Mental Disorder Treatment Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Mental Disorder Treatment Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Mental Disorder Treatment Product Solution and Service

    Table 21. Date of Enter into Mental Disorder Treatment Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Mental Disorder Treatment Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Mental Disorder Treatment Revenue Market Share by Type (2018-2023)

    Table 25. Global Mental Disorder Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Mental Disorder Treatment Revenue Market Share by Type (2024-2029)

    Table 27. Global Mental Disorder Treatment Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Mental Disorder Treatment Revenue Market Share by Application (2018-2023)

    Table 29. Global Mental Disorder Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Mental Disorder Treatment Revenue Market Share by Application (2024-2029)

    Table 31. North America Mental Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Mental Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Mental Disorder Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Mental Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Mental Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Mental Disorder Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Mental Disorder Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Mental Disorder Treatment Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Mental Disorder Treatment Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Mental Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Mental Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Mental Disorder Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Mental Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Mental Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Mental Disorder Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Allergan Plc Company Detail

    Table 47. Allergan Plc Business Overview

    Table 48. Allergan Plc Mental Disorder Treatment Product

    Table 49. Allergan Plc Revenue in Mental Disorder Treatment Business (2018-2023) & (US$ Million)

    Table 50. Allergan Plc Recent Development

    Table 51. Eli Lilly and Company Company Detail

    Table 52. Eli Lilly and Company Business Overview

    Table 53. Eli Lilly and Company Mental Disorder Treatment Product

    Table 54. Eli Lilly and Company Revenue in Mental Disorder Treatment Business (2018-2023) & (US$ Million)

    Table 55. Eli Lilly and Company Recent Development

    Table 56. VistaGen Therapeutics Company Detail

    Table 57. VistaGen Therapeutics Business Overview

    Table 58. VistaGen Therapeutics Mental Disorder Treatment Product

    Table 59. VistaGen Therapeutics Revenue in Mental Disorder Treatment Business (2018-2023) & (US$ Million)

    Table 60. VistaGen Therapeutics Recent Development

    Table 61. Sanofi S.A Company Detail

    Table 62. Sanofi S.A Business Overview

    Table 63. Sanofi S.A Mental Disorder Treatment Product

    Table 64. Sanofi S.A Revenue in Mental Disorder Treatment Business (2018-2023) & (US$ Million)

    Table 65. Sanofi S.A Recent Development

    Table 66. Novartis International AG Company Detail

    Table 67. Novartis International AG Business Overview

    Table 68. Novartis International AG Mental Disorder Treatment Product

    Table 69. Novartis International AG Revenue in Mental Disorder Treatment Business (2018-2023) & (US$ Million)

    Table 70. Novartis International AG Recent Development

    Table 71. Mylan N.V Company Detail

    Table 72. Mylan N.V Business Overview

    Table 73. Mylan N.V Mental Disorder Treatment Product

    Table 74. Mylan N.V Revenue in Mental Disorder Treatment Business (2018-2023) & (US$ Million)

    Table 75. Mylan N.V Recent Development

    Table 76. Amneal Pharmaceuticals LLC Company Detail

    Table 77. Amneal Pharmaceuticals LLC Business Overview

    Table 78. Amneal Pharmaceuticals LLC Mental Disorder Treatment Product

    Table 79. Amneal Pharmaceuticals LLC Revenue in Mental Disorder Treatment Business (2018-2023) & (US$ Million)

    Table 80. Amneal Pharmaceuticals LLC Recent Development

    Table 81. Cipla Ltd Company Detail

    Table 82. Cipla Ltd Business Overview

    Table 83. Cipla Ltd Mental Disorder Treatment Product

    Table 84. Cipla Ltd Revenue in Mental Disorder Treatment Business (2018-2023) & (US$ Million)

    Table 85. Cipla Ltd Recent Development

    Table 86. Sun Pharmaceutical Industries Ltd Company Detail

    Table 87. Sun Pharmaceutical Industries Ltd Business Overview

    Table 88. Sun Pharmaceutical Industries Ltd Mental Disorder Treatment Product

    Table 89. Sun Pharmaceutical Industries Ltd Revenue in Mental Disorder Treatment Business (2018-2023) & (US$ Million)

    Table 90. Sun Pharmaceutical Industries Ltd Recent Development

    Table 91. Glenmark Pharmaceuticals Limited Company Detail

    Table 92. Glenmark Pharmaceuticals Limited Business Overview

    Table 93. Glenmark Pharmaceuticals Limited Mental Disorder Treatment Product

    Table 94. Glenmark Pharmaceuticals Limited Revenue in Mental Disorder Treatment Business (2018-2023) & (US$ Million)

    Table 95. Glenmark Pharmaceuticals Limited Recent Development

    Table 96. Lupin Limited Company Detail

    Table 97. Lupin Limited Business Overview

    Table 98. Lupin Limited Mental Disorder Treatment Product

    Table 99. Lupin Limited Revenue in Mental Disorder Treatment Business (2018-2023) & (US$ Million)

    Table 100. Lupin Limited Recent Development

    Table 101. Janssen Pharmaceutica Company Detail

    Table 102. Janssen Pharmaceutica Business Overview

    Table 103. Janssen Pharmaceutica Mental Disorder Treatment Product

    Table 104. Janssen Pharmaceutica Revenue in Mental Disorder Treatment Business (2018-2023) & (US$ Million)

    Table 105. Janssen Pharmaceutica Recent Development

    Table 106. Bristol Myers Squibb Company Detail

    Table 107. Bristol Myers Squibb Business Overview

    Table 108. Bristol Myers Squibb Mental Disorder Treatment Product

    Table 109. Bristol Myers Squibb Revenue in Mental Disorder Treatment Business (2018-2023) & (US$ Million)

    Table 110. Bristol Myers Squibb Recent Development

    Table 111. Sumitomo Dainippon Pharma Co., Ltd Company Detail

    Table 112. Sumitomo Dainippon Pharma Co., Ltd Business Overview

    Table 113. Sumitomo Dainippon Pharma Co., Ltd Mental Disorder Treatment Product

    Table 114. Sumitomo Dainippon Pharma Co., Ltd Revenue in Mental Disorder Treatment Business (2018-2023) & (US$ Million)

    Table 115. Sumitomo Dainippon Pharma Co., Ltd Recent Development

    Table 116. Research Programs/Design for This Report

    Table 117. Key Data Information from Secondary Sources

    Table 118. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Mental Disorder Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Mental Disorder Treatment Market Share by Type: 2022 VS 2029

    Figure 3. Medications Features

    Figure 4. Self-help Therapies Features

    Figure 5. Global Mental Disorder Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Mental Disorder Treatment Market Share by Application: 2022 VS 2029

    Figure 7. Depression Case Studies

    Figure 8. Bipolar Disorder Case Studies

    Figure 9. Schizophrenia Case Studies

    Figure 10. Dementia Case Studies

    Figure 11. Post-traumatic Stress Disorder Case Studies

    Figure 12. Others Case Studies

    Figure 13. Mental Disorder Treatment Report Years Considered

    Figure 14. Global Mental Disorder Treatment Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 15. Global Mental Disorder Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Mental Disorder Treatment Market Share by Region: 2022 VS 2029

    Figure 17. Global Mental Disorder Treatment Market Share by Players in 2022

    Figure 18. Global Top Mental Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mental Disorder Treatment as of 2022)

    Figure 19. The Top 10 and 5 Players Market Share by Mental Disorder Treatment Revenue in 2022

    Figure 20. North America Mental Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. North America Mental Disorder Treatment Market Share by Country (2018-2029)

    Figure 22. United States Mental Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Canada Mental Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Mental Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Mental Disorder Treatment Market Share by Country (2018-2029)

    Figure 26. Germany Mental Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. France Mental Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. U.K. Mental Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Italy Mental Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Russia Mental Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Nordic Countries Mental Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Mental Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Mental Disorder Treatment Market Share by Region (2018-2029)

    Figure 34. China Mental Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Japan Mental Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. South Korea Mental Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Southeast Asia Mental Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. India Mental Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Australia Mental Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Mental Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Mental Disorder Treatment Market Share by Country (2018-2029)

    Figure 42. Mexico Mental Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Brazil Mental Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Mental Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Mental Disorder Treatment Market Share by Country (2018-2029)

    Figure 46. Turkey Mental Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Saudi Arabia Mental Disorder Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Allergan Plc Revenue Growth Rate in Mental Disorder Treatment Business (2018-2023)

    Figure 49. Eli Lilly and Company Revenue Growth Rate in Mental Disorder Treatment Business (2018-2023)

    Figure 50. VistaGen Therapeutics Revenue Growth Rate in Mental Disorder Treatment Business (2018-2023)

    Figure 51. Sanofi S.A Revenue Growth Rate in Mental Disorder Treatment Business (2018-2023)

    Figure 52. Novartis International AG Revenue Growth Rate in Mental Disorder Treatment Business (2018-2023)

    Figure 53. Mylan N.V Revenue Growth Rate in Mental Disorder Treatment Business (2018-2023)

    Figure 54. Amneal Pharmaceuticals LLC Revenue Growth Rate in Mental Disorder Treatment Business (2018-2023)

    Figure 55. Cipla Ltd Revenue Growth Rate in Mental Disorder Treatment Business (2018-2023)

    Figure 56. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Mental Disorder Treatment Business (2018-2023)

    Figure 57. Glenmark Pharmaceuticals Limited Revenue Growth Rate in Mental Disorder Treatment Business (2018-2023)

    Figure 58. Lupin Limited Revenue Growth Rate in Mental Disorder Treatment Business (2018-2023)

    Figure 59. Janssen Pharmaceutica Revenue Growth Rate in Mental Disorder Treatment Business (2018-2023)

    Figure 60. Bristol Myers Squibb Revenue Growth Rate in Mental Disorder Treatment Business (2018-2023)

    Figure 61. Sumitomo Dainippon Pharma Co., Ltd Revenue Growth Rate in Mental Disorder Treatment Business (2018-2023)

    Figure 62. Bottom-up and Top-down Approaches for This Report

    Figure 63. Data Triangulation

    Figure 64. Key Executives Interviewed